[1]Center for Epidemiological Studies and Clinical Trials,Shanghai Key Laboratory of Hypertension,Shanghai Institute of Hypertension,Department of Hypertension,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China;
[1]Center for Epidemiological Studies and Clinical Trials,Shanghai Key Laboratory of Hypertension,Shanghai Institute of Hypertension,Department of Hypertension,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China;
[1]Center for Epidemiological Studies and Clinical Trials,Shanghai Key Laboratory of Hypertension,Shanghai Institute of Hypertension,Department of Hypertension,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China;
[1]Center for Epidemiological Studies and Clinical Trials,Shanghai Key Laboratory of Hypertension,Shanghai Institute of Hypertension,Department of Hypertension,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China;
[2]Sydney Medical School,The University of Sydney,Concord Hospital,Department of Cardiology and Anzac Research Institute,Sydney,Australia;
randomized controlled trial; atrial fibrillation; screening; automated electrocardiographic analysis system; design;